Skip to main content
TipRanks
Go Ultimate75% OFF

Medi Lifestyle Limited (Z4D) AI Stock Analysis

0 Followers
SG:Z4D

Medi Lifestyle Limited

(SGX:Z4D)

Select Model
Rating:39Underperform
Price Target:SGD 0.04â–¼(-5.13% Downside)
Action:downgraded
Date:10/16/26

The overall score is extremely low, driven primarily by severe financial distress including insolvency, persistent unprofitability, and negative cash flows. This is compounded by a very weak technical trend with the stock in a sustained downtrend across all key moving averages. The negative P/E ratio and lack of a dividend offer no valuation support.

Positive Factors
Improving cash-burn trendAlthough cash generation remains negative, the stated improvement in cash burn versus some prior annual periods suggests early progress in operating discipline. If sustained, this could reduce funding pressure and provide a more credible foundation for eventual self-financing.
Negative Factors
Severe revenue contractionThe sharp TTM revenue decline indicates substantial deterioration in the company’s commercial scale and weak near-term demand conversion. A smaller revenue base makes fixed costs harder to absorb, reduces operating leverage, and raises the difficulty of restoring sustainable profitability.

Medi Lifestyle Limited (Z4D) vs. iShares MSCI Singapore ETF (EWS)

-200%0%200%400%600%800%SG:Z4D+290.00%EWS+6.71%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
SGD 18.72M
Dividend Yield
―
Average Volume (3M)
7.47M
Price to Earnings (P/E)
-8.0
Beta (1Y)
0.74
Revenue Growth
-86.50%
EPS Growth
32.35%
Country
Singapore
Employees
156
Sector
Healthcare
Sector Strength
51
Industry
Medical - Care Facilities

Medi Lifestyle Limited Business Overview & Revenue Model

Company Description

Medi Lifestyle Limited is an investment holding firm that offers a range of services, including placement solutions, across Malaysia, Singapore, and China. The company's operations are divided into three core segments: Healthcare, Outsourced Services...

Medi Lifestyle Limited Financial Statement Overview

Summary

Financial health is critically weak. The company is unprofitable with a -593% net margin, negative gross profit, and a sharp -47.8% TTM revenue decline. The balance sheet is insolvent with negative equity, and cash flows are consistently negative, indicating an unsustainable cash burn.

Income Statement

6Very Negative

Balance Sheet

4Very Negative

Cash Flow

5Very Negative
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue697.95K4.42M1.84M1.94M2.40M1.40M
Gross Profit-57.51K-54.02K-211.71K154.33K92.91K491.58K
EBITDA-3.71M-3.71M-4.69M-6.18M-3.49M-9.15M
Net Income-4.14M-3.86M-5.34M-7.19M-4.30M-23.72M
Balance Sheet
Total Assets5.10M845.76K1.86M811.50K2.18M4.03M
Cash, Cash Equivalents and Short-Term Investments4.73M261.30K1.07M106.11K510.06K1.22M
Total Debt1.24M1.20M1.57M3.84M3.53M4.96M
Total Liabilities12.67M6.33M3.45M10.03M10.89M9.96M
Stockholders Equity-7.57M-5.48M-1.59M-9.22M-8.71M-5.93M
Cash Flow
Free Cash Flow-2.40M-3.98M-6.54M-6.83M-2.31M-4.31M
Operating Cash Flow-2.39M-3.98M-6.54M-6.81M-2.12M-4.11M
Investing Cash Flow-4,000-3,8500-24.83K-191.16K-197.61K
Financing Cash Flow5.82M3.18M7.54M6.38M1.44M5.02M

Medi Lifestyle Limited Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

SG:Z4D against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
SG:OTXSG:OTX74OutperformSGD 29.60M8.7219.60%11.45%-3.11%-21.50%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
SG:V8YSG:V8Y44NeutralSGD 12.59M-3.33118.31%―2.08%-50.00%
SG:Z4DSG:Z4D39UnderperformSGD 29.08M-7.9670.68%―-86.50%32.35%

* Healthcare Sector Average

Performance Comparison

0%200%400%600%SG:Z4DSG:505SG:FRQSG:OTXSG:PRHDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
SG:Z4D and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
SG:Z4DMedi Lifestyle Limited0.040.03290.00%
SG:505Asiamedic Limited0.02-0.00-5.56%
SG:FRQSingapore Paincare Holdings Limited0.06-0.10-62.03%
SG:OTXMedinex Ltd.0.22-0.00-1.35%
SG:PRHLivingstone Health Holdings Limited0.02-0.01-28.57%

Medi Lifestyle Limited Corporate Events

Medi Lifestyle Discontinues EM2AI Acquisition Term Sheet

Nov 20, 2026

Medi Lifestyle Limited and Q & M Dental Group (Singapore) Limited have mutually agreed not to proceed with the proposed acquisition of 60% of EM2AI Pte. Ltd. after the three-month exclusivity period expired on 13 November 2026. No definitive agreemen...

Medi Lifestyle Details Use of S$8.6 Million Share Placement Proceeds

Sep 16, 2026

Medi Lifestyle Limited has completed a placement of 178,588,000 new shares, raising net proceeds of about S$8.59 million after expenses. The funds are earmarked for repaying a shareholder loan, supporting general working capital, and financing busine...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 16, 2026